Results 231 to 240 of about 713,550 (341)
The Future of Antiplatelet Therapy: Optimizing Management in Patients with Acute Coronary Syndrome [PDF]
Eric J. Topol
openalex +1 more source
Takotsubo cardiomyopathy during armed conflict: A case series
ESC Heart Failure, Volume 12, Issue 2, Page 1494-1498, April 2025.
Sharon Bruoha+13 more
wiley +1 more source
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García+17 more
wiley +1 more source
Association of Abnormal Glucose Metabolism and Inflammation With Prognosis in Patients With Acute Coronary Syndrome. [PDF]
Zhang C+5 more
europepmc +1 more source
Management of patients with non-ST-segment elevation acute coronary syndromes: Insights from the pursuit trial [PDF]
Dan J. Fintel, Gary S. Ledley
openalex +1 more source
Abstract Aims Inflammation plays a critical role in both the development and progression of heart failure (HF), which is a leading cause of morbidity and mortality worldwide. However, the causality between specific inflammation‐related proteins and HF risk remains unclear.
Xian‐Guan Zhu+9 more
wiley +1 more source
Adding Ezetimibe to High-Intensity Statin at the Time of Admission in Patients With Acute Coronary Syndrome: Results From the Optimization of Low-Density Lipoprotein Cholesterol After Acute Coronary Syndrome (OLA) Study. [PDF]
Mahajan K+6 more
europepmc +1 more source
Abstract Background and objectives Initially described as a benign acute cardiomyopathy, Takotsubo syndrome has been linked to elevated mortality rates. Emerging evidence suggests that unresolved myocardial inflammation may contribute to this adverse prognosis.
Loïc Faucher+12 more
wiley +1 more source
Intensive Lipid-Lowering Therapy Following Acute Coronary Syndrome: The Earlier the Better. [PDF]
Pradhan A+5 more
europepmc +1 more source